B+
Bull case
30%
Probability
Target price
$1,600.00
Analysis reference price unavailable
Analysis 2026-08-04 · RankAlpha Sentiment Codex
MTD
Mettler-Toledo InternationalANYSE / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
AI scenario view
RankAlpha Sentiment CodexPost-earnings T+3Most likely
B
Base case
45%
Probability
Target price
$1,496.00
Analysis reference price unavailable
Analysis 2026-08-04 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$1,340.00
Analysis reference price unavailable
Analysis 2026-08-04 · RankAlpha Sentiment Codex
The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented
AI sentiment snapshot
Latest data as of 2026-08-04
Recent news sentiment (30D)
+0.7
Mixed
Company
-
Unavailable
Macro
-
Unavailable
Pulse
-
Unavailable
Weekly research (10D)
-
Unavailable
Sentiment proxy
+82.5
Score
AI commentary
News tone is positive after the Q2 release and guidance raise. Market-price history showed shares up 2.59% on July 31 and 2.03% on August 3, with the August 4 session lower intraday; the move is directionally supportive but not fully attributable to earnings. Post-print analyst revisions are available and net positive but mixed. Options, short-interest, employee, social, and direct-peer evidence remain unavailable, so the memo remains monitoring-oriented.
RankAlpha Sentiment Codex - 2026-08-04
Open post-earnings memoEvidence flagged
peer set is too generic or lacks enough direct operating comparators; later post-earnings follow-up lacks concrete company-source and analyst/market reaction evidence
Impact
tentative
Confidence
-
AI events
2026-07-30eventQ2 2026 beat and full-year guidance raiseMedium impact
Q2 adjusted EPS was $11.46, up 14% year over year; local-currency sales rose 6% excluding the customer tariff refund. Management raised full-year 2026 adjusted EPS guidance to $47.15-$47.50 from $46.30-$46.95 and sales growth guidance to 4%-5%. [#SEC-8K-2026-07-30]
2026-08-15catalystPost-print analyst revisions and price follow-throughMedium impact
Post-print reports showed Stifel raising its target from $1,400 to $1,600 while retaining Buy, Barclays raising $1,300 to $1,575, Jefferies raising $1,400 to $1,580, and Morgan Stanley raising $1,275 to $1,450 while retaining Equal Weight. Goldman Sachs maintained Hold and reduced its target from $1,400 to $1,340, leaving the revision signal positive but mixed.
2027-07-30catalystChina recovery and automation-led demandHigh impact
Management cited improving China and emerging-market demand, the Spinnaker sales program, innovation, automation, digitalization, and onshoring as longer-term growth drivers. [#EARNINGS-TRANSCRIPT-2026Q2]
Recommendation
N/A
No formal recommendation provided.
As of 2026-08-04 • Updated nightlySource: Internal modelMethodology